Exscientia Stock: Drug Discovery Platform Attracting Partners And Cash (NASDAQ:EXAI)


Doctor working in lab during COVID-19 outbreak

Morsa Images

As Generative AI impacts drug research, this thesis aims to uncover the opportunities for Exscientia plc (NASDAQ:EXAI) and show it is a buy based on the strength of its technology platform. Noteworthily, I was again bullish when covering

Leave a Reply

Your email address will not be published. Required fields are marked *